What is the recommended acute management for a patient with vestibular migraine who is currently taking sumatriptan?

Acute Management of Vestibular Migraine in Patients Taking Sumatriptan

Add an NSAID (such as naproxen 500 mg or ibuprofen) to the sumatriptan regimen, as combination therapy with a triptan plus NSAID provides superior efficacy compared to monotherapy for acute migraine treatment. 1

Optimizing Current Sumatriptan Therapy

Since the patient is already taking sumatriptan, the most evidence-based approach is to enhance its effectiveness through combination therapy rather than switching agents. The 2025 American College of Physicians guideline strongly recommends combining a triptan with an NSAID for moderate to severe episodic migraine 1. This combination approach:

• Improves pain freedom and relief rates at 2 hours compared to either agent alone
• Reduces relapse rates within 24-48 hours after initial treatment 2
• Should be initiated as early as possible when headache is still mild for maximum efficacy 1

Specific Considerations for Vestibular Migraine

While the general principles of migraine treatment apply, vestibular migraine has important distinctions:

• Triptans should NOT be used for isolated vertigo/dizziness episodes without accompanying migraine features 3
• Sumatriptan is appropriate when vestibular symptoms occur with concurrent headache, visual aura, or photophobia/phonophobia 3, 4
• For attacks with severe nausea or vomiting, consider non-oral sumatriptan formulations (subcutaneous injection) plus an antiemetic 1, 2

Treatment Algorithm

For acute attacks:

1. Combination therapy first-line: Sumatriptan (50-100 mg) + naproxen sodium (500 mg) or ibuprofen (400-800 mg) 1, 5
2. Take medication at onset when pain is mild rather than waiting for severe symptoms 1
3. If inadequate response after 2 hours, acetaminophen may be added 1
4. A second dose may be taken 4-24 hours later for recurrent headache, but counsel about medication overuse headache risk 1

If combination therapy fails after adequate trial (3 consecutive attacks):

• Consider CGRP antagonists (rimegepant, ubrogepant, zavegepant) 1
• Lasmiditan as last-line option if all other treatments fail 1

Critical Warnings

Medication overuse headache threshold: Triptans carry risk at ≥10 days per month of use (lower than NSAIDs at ≥15 days/month) 1. If attacks are frequent, prophylactic therapy becomes essential.

Avoid completely: Opioids and butalbital have no role in acute migraine treatment 1

When Prophylaxis is Needed

If the patient requires acute treatment frequently or has inadequate response, add preventive medication 1. For vestibular migraine specifically:

• Flunarizine is first-line prophylaxis based on randomized trial evidence 6
• Venlafaxine for patients with comorbid anxiety, depression, or persistent postural-perceptual dizziness overlap 7
• Topiramate for headache-predominant phenotype with marked sensory hypersensitivity 7
• Propranolol as alternative second-line option 6

Adjunctive Measures

• Vestibular rehabilitation may provide prophylactic benefit for vestibular migraine 6, 4
• Address lifestyle factors: hydration, regular meals, consistent sleep, aerobic exercise, stress management 1
• Identify and manage modifiable triggers through detailed history 1